Amgen Inc.
METHOD FOR ENHANCING PRODUCTION OF GENETICALLY ENGINEERED AUTOLOGOUS T CELLS
Last updated:
Abstract:
The present invention relates to a method for enhancing production of autologous genetically engineered T cells for use in cell therapy applications.
Status:
Application
Type:
Utility
Filling date:
13 Apr 2021
Issue date:
21 Oct 2021